- Home
- PTGX vs AKR Comparison
PTGX vs AKR Comparison
Compare PTGX & AKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- AKR
- Stock Information
- Founded
- PTGX 2006
- AKR 1993
- Country
- PTGX United States
- AKR United States
- Employees
- PTGX N/A
- AKR N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- AKR Real Estate Investment Trusts
- Sector
- PTGX Health Care
- AKR Real Estate
- Exchange
- PTGX Nasdaq
- AKR Nasdaq
- Market Cap
- PTGX 2.9B
- AKR 2.5B
- IPO Year
- PTGX 2016
- AKR 1993
- Fundamental
- Price
- PTGX $53.34
- AKR $19.04
- Analyst Decision
- PTGX Strong Buy
- AKR Strong Buy
- Analyst Count
- PTGX 9
- AKR 3
- Target Price
- PTGX $67.11
- AKR $22.67
- AVG Volume (30 Days)
- PTGX 898.5K
- AKR 1.1M
- Earning Date
- PTGX 08-05-2025
- AKR 07-29-2025
- Dividend Yield
- PTGX N/A
- AKR 4.16%
- EPS Growth
- PTGX N/A
- AKR 83.39
- EPS
- PTGX 0.86
- AKR 0.17
- Revenue
- PTGX $207,801,000.00
- AKR $387,331,000.00
- Revenue This Year
- PTGX N/A
- AKR N/A
- Revenue Next Year
- PTGX $47.15
- AKR $11.00
- P/E Ratio
- PTGX $62.27
- AKR $116.27
- Revenue Growth
- PTGX N/A
- AKR 13.53
- 52 Week Low
- PTGX $30.67
- AKR $16.98
- 52 Week High
- PTGX $60.60
- AKR $26.29
- Technical
- Relative Strength Index (RSI)
- PTGX 58.33
- AKR 41.97
- Support Level
- PTGX $54.48
- AKR $19.06
- Resistance Level
- PTGX $57.18
- AKR $19.48
- Average True Range (ATR)
- PTGX 2.04
- AKR 0.40
- MACD
- PTGX -0.09
- AKR -0.02
- Stochastic Oscillator
- PTGX 57.13
- AKR 15.00
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About AKR Acadia Realty Trust
Acadia Realty Trust is a real estate investment trust that specializes in the operation, management, leasing, renovation, and acquisition of shopping centers and mixed-use properties with retail components. The company operates through three segments: Core Portfolio segment consists primarily of high-quality retail properties located primarily in high-barrier-to-entry, densely-populated metropolitan areas with a long-term investment horizon; Investment Management segment holds primarily retail real estate in which the company co-invests with high-quality institutional investors; and Structured Financing segment consists of earnings and expenses related to notes and mortgages receivable Fees earned by the company as the general partner or managing member through Investment Management.